Pursuant to Regulation 30 and 33 of SEBI (LODR) regulations, 2015, as amended from time to time. We enclosed herewith Unaudited Standalone and Consolidated Financial results of the company for the ...

Going public via SPAC was a very 2021 thing to do. During the peak of the last bull market, dozens of startups took this quick route to market, merging with publicly traded shell companies, or SPACs, ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

In the basement of 55 Church St. sits one of just three NeuroExplorer PET scanners in the world. Capable of producing images with significantly better resolution and sensitivity than its 20-year-old ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.

Biotech firm Jade Biosciences Inc. has completed its merger with Aerovate Therapeutics Inc. (Nasdaq:AVTE), in a move that will put the former on the Nasdaq. Jade’s Vancouver-based CEO, Tom ...

PITTSBURGH, April 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that on April 23, 2025, the European Commission (EC) granted marketing ...

Rather, with so much uncertainty, investors are prizing biotech companies that base their intellectual property and manufacturing in the U.S., which up until now often meant higher taxes.

Today, almost all available birth control options are female contraceptives. Biotech company Contraline, however, claims that clinical trials for its non-hormonal and reversible male contraceptive ...